Myriad Genetics Inc (LTS:0K3W)
$ 2.9 -2.258 (-43.78%) Market Cap: 270.12 Mil Enterprise Value: 365.42 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 54/100

Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 01:15 AM GMT
Release Date Price: $6.02 (-0.11%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MYGN.OQ - Myriad Genetics Inc
Myriad Genetics Inc at JPMorgan Healthcare Conference
Jan 15, 2026 / 01:15AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good evening ladies and gentlemen.

I'm Dishayuk Kapadia. I'm an associate with the Healthcare Investment Banking Group at JPMorgan.

I'm, it's my pleasure to welcome you to the company presentation for Myriad Genetics. Today, we are joined by SAM Raha, who is the President and CEO at Myriad, who will be taking us through the presentation, and SAM is also joined by Ben Miller, who will be joining us for the Q&A. Ben serves as the, Chief Financial Officer at Myriad.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much.

Good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot